P2X4 receptors, immunity, and sepsis

Area of Science:

• Immunology
• Pharmacology
• Critical Care Medicine

Background:

• Sepsis is a life-threatening organ dysfunction due to a dysregulated host response to infection.
• Current sepsis treatments (antibiotics, fluids, supportive care) have high mortality and morbidity.
• Novel therapeutic targets are urgently needed to improve sepsis outcomes.

Purpose of the Study:

• To review the role of P2 purinergic receptors in sepsis.
• To highlight the P2X4 receptor as a potential therapeutic target for sepsis treatment.

Main Methods:

• Literature review of studies investigating P2 purinergic receptors in sepsis.
• Analysis of research on the P2X4 receptor's function in infection, inflammation, and organ injury.

Main Results:

• P2 purinergic receptors modulate host responses to infection.
• The P2X4 receptor demonstrates protective effects against infection, inflammation, and organ injury.
• P2X4 receptor activity is implicated in sepsis pathogenesis and progression.

Conclusions:

• The P2X4 receptor is a promising target for novel sepsis therapies.
• Targeting the P2X4 receptor may offer a new strategy to improve sepsis treatment and patient outcomes.